Loading…
Kura Oncology, Inc. is projected to rise to $16.37 by 2027, a +43% move from its current price of $11.45. KURA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $11.10 | $11.45 | $11.81 | +0.01% |
| Jul 14 | $10.96 | $11.45 | $11.96 | +0.02% |
| Jul 15 | $10.85 | $11.45 | $12.08 | +0.03% |
| Jul 16 | $10.77 | $11.45 | $12.19 | +0.03% |
| Jul 17 | $10.69 | $11.45 | $12.28 | +0.04% |
| Jul 18 | $10.62 | $11.46 | $12.36 | +0.05% |
| Jul 19 | $10.56 | $11.46 | $12.44 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.56 | $11.46 | $12.44 | +0.06% |
| Week 2 | $10.21 | $11.46 | $12.87 | +0.12% |
| Week 3 | $9.95 | $11.47 | $13.22 | +0.18% |
| Week 4 | $9.74 | $11.48 | $13.52 | +0.23% |
| Week 5 | $9.56 | $11.48 | $13.79 | +0.29% |
| Week 6 | $9.40 | $11.49 | $14.04 | +0.35% |
| Week 7 | $9.26 | $11.50 | $14.28 | +0.41% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer. The company’s first commercial product, KOMZIFTI (ziftomenib), is described as a potent, selective, reversible and oral small molecule menin inhibitor.
Darlifarnib is in a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications. KO-7246 is a next-generation menin inhibitor for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Kura Oncology, Inc. trades with a current price of $11.99 and a market cap of $1.06B, ranking 2523 by market position. This snapshot places the stock among smaller-cap healthcare peers with a focused oncology portfolio.
A major floor 37.6% below — a decisive break under it would weaken the trend.
The nearest floor, 25.2% below — buyers have tended to step in here.
The nearest ceiling, 5.9% above — a clean break opens room to run.
A major ceiling 24.6% above — clearing it would confirm fresh momentum.
Key KURA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KURA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.74 | Sell | $11.64 | Sell |
| MA 10 | $11.34 | Buy | $11.33 | Buy |
| MA 20 | $10.57 | Buy | $10.81 | Buy |
| MA 50 | $9.88 | Buy | $10.08 | Buy |
| MA 100 | $9.30 | Buy | $9.65 | Buy |
| MA 200 | $9.56 | Buy | $9.41 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.88 | Neutral |
| Stoch RSI (14) | 8.90 | Buy |
| CCI (20) | 75.77 | Neutral |
| Williams %R (14) | -38.07 | Info |
| MACD (12,26,9) | 0.13 | Buy |
| ROC (12) | 10.31 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 61.93 | Neutral |
| TRIX (15) | 0.70 | Buy |
| Awesome (5,34) | 1.59 | Buy |
| Ultimate (7,14,28) | 62.67 | Neutral |
| Momentum (10) | 1.09 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 12.19 | Sell |
| ADX (14) | 26.64 | Buy |
| ATR (14) | 0.29 | Info |
The technical picture is bullish, with RSI at 70 and the stock trading near key levels. The SMA50 is $9.71 and the SMA200 is $9.51, providing a near-term upward drift. Immediate support sits at $8.56 and resistance at $11.99, with a 30-day range from $9.73 to $14.78.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.40 | $11.45 | $15.62 | 0% | Neutral | |
| $12.87 | $16.37 | $22.12 | +43% | Bullish | |
| $15.59 | $20.47 | $28.83 | +79% | Bullish | |
| $15.68 | $21.15 | $30.75 | +85% | Bullish | |
| $16.93 | $23.39 | $34.94 | +104% | Bullish | |
| $18.70 | $26.40 | $40.37 | +131% | Bullish | |
| $18.27 | $26.31 | $41.09 | +130% | Bullish | |
| $21.51 | $31.58 | $50.26 | +176% | Bullish | |
| $25.97 | $38.82 | $62.87 | +239% | Bullish | |
| $28.43 | $43.24 | $71.16 | +278% | Bullish | |
| $35.79 | $58.93 | $103.75 | +415% | Bullish | |
| $72.26 | $136.76 | $265.43 | +10.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $7.40 | $11.45 | $13.72 | +0.00% |
| August 2026 | $9.48 | $11.23 | $13.69 | -1.91% |
| September 2026 | $9.66 | $11.54 | $14.24 | +2.73% |
| October 2026 | $10.06 | $12.09 | $15.08 | +4.78% |
| November 2026 | $10.02 | $12.12 | $15.25 | +0.24% |
| December 2026 | $10.13 | $12.31 | $15.62 | +1.58% |
Click any year to see its month-by-month KURA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, KURA is projected to trade between $7.40 and $15.62, averaging $11.45 — a potential gain of 0% from today's $11.45. Price action looks broadly range-bound.
Kura Oncology, Inc.'s 2027 outlook centres on $16.37, within a $12.87 to $22.12 range. That is up +43% on the projected 2026 average. That marks a +43% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, KURA could reach as high as $28.83, with a base case around $20.47 and support toward $15.59 — roughly +79% from $11.45. Momentum favours further upside here.
Expect KURA to range from $15.68 to $30.75 through 2029. The $21.15 average target implies a +85% move from current prices. That is up +3% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The KURA price prediction for 2030 points to an average of $23.39 (low $16.93, high $34.94) — a potential gain of +104% on today's $11.45. Momentum favours further upside here.
In 2031, KURA is projected to trade between $18.70 and $40.37, averaging $26.40 — a potential gain of +131% from today's $11.45. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Kura Oncology, Inc.'s 2032 outlook centres on $26.31, within a $18.27 to $41.09 range. That is 0% versus the projected 2031 average. That marks a +130% change versus current levels. Momentum favours further upside here.
By 2033, KURA could reach as high as $50.26, with a base case around $31.58 and support toward $21.51 — roughly +176% from $11.45. Buyers look set to stay in control over this stretch.
Expect KURA to range from $25.97 to $62.87 through 2034. The $38.82 average target implies a +239% move from current prices. That is up +23% on the projected 2033 average. Momentum favours further upside here.
The KURA price prediction for 2035 points to an average of $43.24 (low $28.43, high $71.16) — a potential gain of +278% on today's $11.45. Buyers look set to stay in control over this stretch.
In 2040, KURA is projected to trade between $35.79 and $103.75, averaging $58.93 — a potential gain of +415% from today's $11.45. That is up +36% on the projected 2035 average. Momentum favours further upside here.
Kura Oncology, Inc.'s 2050 outlook centres on $136.76, within a $72.26 to $265.43 range. That is up +132% on the projected 2040 average. That marks a +10.9x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in KURA today (≈ 87.336245 KURA) could be worth
$11,943.82
+$10,943.82 (+1094%) by 2050 · US Dollar
Based on the average projected KURA price of $136.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KURAwould be worth at today's price.
$1,000 invested in KURA on Jul 10, 2025 (≈ 157.232701 KURA) would be worth
$1,800.31
+$800.31 (+80.0%) today · 1.80× · US Dollar
Based on a KURA entry price of $6.36 vs. today's $11.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.1 | $1,031.53 | +3.2% |
| 1 month ago | $8.68 | $1,319.12 | +31.9% |
| 3 months ago | $8.67 | $1,320.65 | +32.1% |
| 6 months ago | $9.17 | $1,248.64 | +24.9% |
| 1 year ago | $6.36 | $1,800.31 | +80.0% |
| All time (5.0y) ago | $18.83 | $608.07 | -39.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KURA forecast.
Our base-case forecast reaches $23.00 around 2030.
Implied market cap at $23.00: $2.04B
Forecasts show a multi-year rise in the average price with increasing upside. For 2026 the min is $7.40, avg is $11.99, max is $16.67 with ROI 0 and sentiment Neutral. From 2027 onward, the average climbs to $17.66 (ROI 47.3) and $22.02 (ROI 83.7) in 2028, with 2029 at $23.04 (ROI 92.2) and 2030 at $25.69 (ROI 114.3) showing continued bullish momentum.
The sequence continues to 2031 ($29.05, ROI 142.3), 2032 ($29.29, ROI 144.3), 2033 ($35.61, ROI 197), 2034 ($44.03, ROI 267.2), and 2035 ($49.27, ROI 310.9). By 2040 the average is projected at $68.03 (ROI 467.4) and by 2050 at $161.50 (ROI 1247); the sentiment remains bullish across these years. These figures illustrate a long-run bullish trajectory, though explicit drivers and risks are not detailed in the data.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $25.69, with a min of $18.50 and a max of $38.61, and a forecasted ROI of 114.3; sentiment is bullish.
Yes. The 30-day technical picture is bullish with RSI14 at 70, and the sentiment is bullish. The stock trades with a current price of $11.99, near a resistance level of $11.99 and above a support of $8.56, within a 30-day range of $9.73 to $14.78.
The forecast shows 2040 max at $120.80 and 2050 max at $316.62, indicating that prices above $100 are within the forecast horizon in later years.
30-day range is $9.73 to $14.78. Support is at $8.56 and resistance at $11.99.
Market cap is $1.06B and the rank is 2523.
Kura Oncology, Inc. Community Discussion
0Share your Kura Oncology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.